STOCK TITAN
  1. Home
  2. Sec-filings
  3. PRVA
  4. [Form 4] Privia Health Group, Inc. Insider Trading Activity

Privia Health (PRVA) director receives 8,463 restricted stock units in equity grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BERBERIAN LANCE reported acquisition or exercise transactions in this Form 4 filing.

Privia Health Group director Lance Berberian reported an equity grant. On May 20, 2026, he received 8,463 restricted stock units under the company’s 2021 Omnibus Incentive Plan. The units will vest on the earlier of the day immediately preceding the 2027 annual stockholders’ meeting or the first anniversary of the grant date.

Following this compensation award, Berberian directly holds 16,131 shares of common stock. The grant was made at no cash cost to him and reflects routine director compensation rather than an open-market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider BERBERIAN LANCE
Role null
Type Security Shares Price Value
Grant/Award Common Stock, $0.01 par value per share 8,463 $0.00 --
Holdings After Transaction: Common Stock, $0.01 par value per share — 16,131 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Restricted stock units granted 8,463 units Award to Lance Berberian on May 20, 2026
Grant price per share $0.00 Equity award with no cash purchase price
Shares held after transaction 16,131 shares Direct holdings of Lance Berberian following grant
restricted stock units financial
"the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2021 Omnibus Incentive Plan financial
"received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan"
annual meeting of stockholders financial
"will vest on the earlier of the day immediately preceding the Company's 2027 annual meeting of stockholders"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BERBERIAN LANCE
(Last)(First)(Middle)
950 N GLEBE RD
SUITE 700
(Street)
ARLINGTON VIRGINIA 22203
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Privia Health Group, Inc. [ PRVA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, $0.01 par value per share05/20/2026A8,463(1)A$016,131D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
Remarks:
/s/ Anita Beth Adams, as attorney-in-fact05/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Privia Health (PRVA) director Lance Berberian report in this Form 4?

He reported receiving 8,463 restricted stock units as a compensation grant. These units were awarded under Privia Health’s 2021 Omnibus Incentive Plan and did not involve any cash purchase, reflecting routine equity-based director compensation rather than an open-market stock transaction.

How many Privia Health (PRVA) shares does Lance Berberian hold after this grant?

After the reported transaction, Lance Berberian directly holds 16,131 shares of Privia Health common stock. This figure comes from the Form 4’s post-transaction ownership line and represents his direct holdings following the award of 8,463 restricted stock units.

What are the vesting terms of Lance Berberian’s 8,463 restricted stock units at Privia Health (PRVA)?

The 8,463 restricted stock units vest on the earlier of two dates: the day immediately before Privia Health’s 2027 annual stockholders’ meeting, or the first anniversary of the May 20, 2026 grant date, according to the Form 4 footnote description.

Did Lance Berberian buy or sell Privia Health (PRVA) shares in this Form 4?

He did not report any open-market buys or sells. The Form 4 shows an acquisition coded as a grant or award of 8,463 restricted stock units, provided as equity compensation rather than a purchase or sale at a market price.

Under which plan were Lance Berberian’s restricted stock units at Privia Health (PRVA) granted?

The restricted stock units were granted under Privia Health’s 2021 Omnibus Incentive Plan. This plan is used to provide equity-based compensation, and the Form 4 footnote specifies it as the source of Berberian’s 8,463-unit award on May 20, 2026.